Evogene (EVGN) Reports Q4 Loss, Misses Revenue Estimates

Evogene (EVGN) came out with a quarterly loss of $0.13 per share versus the Zacks Consensus Estimate of a loss of $0.14. This compares to loss of $0.07 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 7.14%. A quarter ago, it was expected that this agricultural company would post a loss of $0.17 per share when it actually produced a loss of $0.08, delivering a surprise of 52.94%.Over the last four quarters, the company has surp ...